Dendritic cells and skin sensitisation hazard assessment

Toxicology in Vitro

Volumn 18, Issue 2, 2004, Pages 195-202

  Kimber, I ^a   Cumberbatch, M ^a   Betts, C J ^a   Dearman, R J ^a  

^a JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

Author keywords

Allergy; Cytokines; Dendritic cells; Hazard identification; Langerhans cells; Skin sensitisation

Indexed keywords

TOXIC SUBSTANCE;

ACCURACY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CONTACT DERMATITIS; DENDRITIC CELL; HEALTH HAZARD; HUMAN; IMMUNITY; IMMUNOBIOLOGY; LANGERHANS CELL; NONHUMAN; REVIEW; RISK ASSESSMENT; SKIN; SKIN SENSITIZATION; SKIN TOXICITY;

EID: 1642493712     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2333(03)00148-6     Document Type: Article

References (74)

1. Aiba S., Manome H., Yoshino Y., Tagami H. In vitro treatment of human transforming growth factor-β1-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction. Immunology. 101:2000;68-75.
2. Aiba S., Terunuma A., Manome H., Tagami H. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. European Journal of Immunology. 27:1997;3031-3038.
3. Antonopoulos C., Cumberbatch M., Dearman R.J., Daniel R.J., Kimber I., Groves R.W. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. Journal of Immunology. 166:2001;3672-3677.
4. Austyn J.M. Mobilization, migration and localization of dendritic cells. Lotze M.T., Thomson A.W. Dendritic Cells: Biology and Clinical Applications, 2nd edition. 2001;131-149 Academic Press, San Diego.
5. Basketter D.A., Blaikie L., Dearman R.J., Kimber I., Ryan C.A., Gerberick G.F., Harvey P., Evans P., White I.R., Rycroft R.J.G. Use of the local lymph node assay for the estimation of relative contact allergenic potency. Contact Dermatitis. 42:2000;344-348.
6. Basketter D.A., Evans P., Fielder R.J., Gerberick G.F., Dearman R.J., Kimber I. Local lymph node assay - validation, conduct and use in practice. Food and Chemical Toxicology. 40:2002;593-598.
7. Basketter D.A., Gerberick G.F., Kimber I., Willis C.M. Toxicology of Contact Dermatitis. Allergy, Irritancy and Urticaria. 1999;Wiley, Chichester.
8. Basketter D.A., Lea L.J., Dickens A., Briggs D., Pate I., Dearman R.J., Kimber I. A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses. Journal of Applied Toxicology. 19:1999;261-266.
9. Bender A., Sapp M., Schuler G., Steinman R.M., Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human peripheral blood. Journal of Immunological Methods. 196:1996;121-135.
10. Buehler E.V. Delayed contact hypersensitivity in the guinea pig. Archives of Dermatology. 91:1965;171-177.
11. Caux C., Dezutter-Dambuyant C., Schmitt D., Banchereau J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature. 360:1992;258-261.
12. Coutant K.D., de Brugerolle de Fraisinette A., Cordier A., Ulrich P. Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal allergen, and a staphylococcal superantigen. Toxicological Sciences. 52:1999;189-198.
13. Cumberbatch M., Dearman R.J., Antonopoulos C., Groves R.W., Kimber I. Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-α- and IL-1β-dependent mechanism. Immunology. 102:2001;323-330.
14. Cumberbatch M., Dearman R.J., Griffiths C.E.M., Kimber I. Langerhans cell migration. Clinical and Experimental Dermatology. 25:2000;413-418.
15. Cumberbatch M., Dearman R.J., Kimber I. Langerhans cells require signals from both tumour necrosis factor-α and interleukin-1β for migration. Immunology. 92:1997;388-395.
16. Cumberbatch M., Griffiths C.E.M., Tucker S.C., Dearman R.J., Kimber I. Tumour necrosis factor-α induces Langerhans cell migration in humans. British Journal of Dermatology. 141:1999;192-200.
17. Cumberbatch M., Kimber I. Tumour necrosis factor-α is required for accumulation of dendritic cells in lymph nodes and for optimal contact sensitization. Immunology. 84:1995;31-35.
18. Dearman R.J., Basketter D.A., Kimber I. Local lymph node assay. use in hazard and risk assessment Journal of Applied Toxicology. 19:1999;299-306.
19. De Silva O., Basketter D.A., Barratt M.D., Corsini E., Cronin M.T.D., Das P.K., Degwert J., Enk A., Garrigue J.L., Hauser C., Kimber I., Lepoittevin J.-P., Peguet J., Ponec M. Alternative methods for skin sensitisation testing. The report and recommendations of the ECVAM workshop 19. Alternatives to Laboratory Animals. 24:1996;683-705.
20. Ebner S., Hofer S., Anh Nguyen V., Furhapter C., Herold M., Fritsch P., Heufler C., Romani N. A novel role for IL-3. human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern Journal of Immunology. 168:2002;6199-6207.
21. Enk A.H., Katz S.I. Early molecular events in the induction phase of contact sensitivity. Proceedings of the National Academy of Sciences USA. 89:1992;1398-1402.
22. Enk A.H., Angeloni V.L., Udey M.C., Katz S.I. An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in the skin. Journal of Immunology. 150:1993;3698-3704.
23. Fields R.C., Shimzu K., Mule J.J. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proceedings of the National Academy of Sciences USA. 95:1998;9482-9488.
24. Forster R., Schubel A., Breitfeld D., Kremmer E., Renner-Muller I., Wolf E., Lipp M. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 99:1999;23-33.
25. Friedmann P.S. The immunobiology of Langerhans cells. Immunology Today. 2:1981;124-128.
26. Gerberick G.F., Robinson M.K., Ryan C.A., Dearman R.J., Kimber I., Basketter D.A., Wright Z., Marks J.G. Contact allergenic potency. correlation of human and local lymph node assay data American Journal of Contact Dermatitis. 12:2001;156-161.
27. Gerberick G.F., Ryan C.A., Kimber I., Dearman R.J., Lea L.J., Basketter D.A. Local lymph node assay. validation assessment for regulatory purposes American Journal of Contact Dermatitis. 11:2000;3-18.
28. Grabbe S., Schwarz T. Immunoregulatory mechanisms involved in the elicitation of allergic contact hypersensitivity. Immunology Today. 19:1998;37-44.
29. Guironnet G., Dezutter-Dambuyant C., Vincent C., Bechetoille N., Schmitt D., Peguet-Navarro J. Antagonistic effects of IL-4 and TGF-β1 on Langerhans cell-related antigen expression by human monocytes. Journal of Leukocyte Biology. 71:2002;845-853.
30. Herouet C., Cottin M., Galanaud P., Leclaire J., Rousset F. Contact sensitizers increase 33D1 expression on mature Langerhans cells. European Journal of Dermatology. 9:1999;185-190.
31. Hulette B.C., Ryan C.A., Gerberick G.F. Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment. Toxicology and Applied Pharmacology. 182:2002;226-233.
32. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony stimulating factor. Journal of Experimental Medicine. 176:1992;1693-1702.
33. Kimber I. Skin sensitisation. immunological mechanisms and novel approaches to predictive testing Balls M., van Zeller A.-M., Halder M.E. Progress in the Reduction, Refinement and Replacement of Animal Experimentation. 2000;613-621 Elsevier Science, Amsterdam.
34. Kimber I., Basketter D.A. The murine local lymph node assay. a commentary on collaborative studies and new directions Food and Chemical Toxicology. 30:1992;165-169.
35. Kimber I., Cumberbatch M. Dendritic cells and cutaneous immune responses to chemical allergens. Toxicology and Applied Pharmacology. 117:1992;137-146.
36. Kimber I., Basketter D.A. Contact sensitization. a new approach to risk assessment Human and Ecological Risk Assessment. 3:1997;385-395.
37. Kimber I., Dearman R.J. Contact hypersensitivity. immunological mechanisms Kimber I., Maurer T. Toxicology of Contact Hypersensitivity. 1996;4-25 Taylor & Francis, London.
38. Kimber I., Dearman R.J. Cell and molecular biology of chemical allergy. Clinical Reviews in Allergy and Immunology. 15:1997;145-168.
39. Kimber I., Dearman R.J. T lymphocyte subpopulations and immune responses to chemical allergens. Kimber I., Selgrade M.K. T Lymphocyte Subpopulations in Immunotoxicology. 1998;199-231 Wiley, Chichester.
40. Kimber I., Dearman R.J. Allergic contact dermatitis. the cellular effectors Contact Dermatitis. 46:2002;1-5.
41. Kimber I., Dearman R.J., Scholes E.W., Basketter D.A. The local lymph node assay. developments and applications Toxicology. 93:1994;13-31.
42. Kimber I., Dearman R.J., Cumberbatch M., Huby R.J.D. Langerhans cells and chemical allergy. Current Opinion in Immunology. 10:1998;614-619.
43. Kimber I., Pichowski J.S., Basketter D.A., Dearman R.J. Immune responses to contact allergens. novel approaches to hazard evaluation Toxicology Letters. 106:1999;237-246.
44. Kimber I., Cumberbatch M., Dearman R.J., Knight S.C. Langerhans cell migration and cellular interactions. Lotze M.T., Thomson A.W. Dendritic Cells. Biology and Clinical Applications. 1999;295-310 Academic Press, San Diego.
45. Kimber I., Cumberbatch M., Dearman R.J., Bhushan M., Griffiths C.E.M. Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. British Journal of Dermatology. 142:2000;401-412.
46. Kimber I., Basketter D.A., Berthold K., Butler M., Garrigue J.-L., Lea L., Newsome C., Roggeband R., Steiling W., Stropp G., Waterman S., Wiemann C. Skin sensitization testing in potency and risk assessment. Toxicological Sciences. 59:2001;198-208.
47. Kimber I., Pichowski J.S., Betts C.J., Cumberbatch M., Basketter D.A., Dearman R.J. Alternative approaches to the identification and characterization of chemical allergens. Toxicology in Vitro. 15:2001;307-312.
48. Kimber I., Basketter D.A., Gerberick G.F., Dearman R.J. Allergic contact dermatitis. International Immunopharmacology. 2:2002;201-211.
49. Kimber I., Cumberbatch M., Dearman R.J., Griffiths C.E.M. Danger signals and skin sensitisation. British Journal of Dermatology. 147:2002;613-614.
50. Kimber I., Dearman R.J., Basketter D.A., Ryan C., Gerberick G.F. The local lymph node assay: past, present and future. Contact Dermatitis. 47:2002;315-328.
51. Le Naour F., Hohenkirk L., Grolleau A., Misek D.E., Lescure P., Geiger J.D., Hanash S., Beratta L. Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics. The Journal of Biological Chemistry. 276:2001;17920-17931.
52. Lenz A., Heine M., Schuler G., Romani M. Human and murine dendritic cells. Isolation by means of a novel method and phenotypical and functional characterisations. Journal of Clinical Investigation. 95:1993;2587-2596.
53. Lutz M.B., Kututsch N., Ogilvie A.L.J., Robner S., Koch F., Romani N., Schuler G. An advanced culture method for generating large quantitities of highly pure dendritic cells from mouse bone marrow. Journal of Immunological Methods. 223:1999;77-92.
54. Magnusson B., Kligman A.M. Allergic Contact Dermatitis in the Guinea Pig. 1970;Charles C Thomas, Springfield.
55. Mahnke K., Guo M., Lee S., Sepulveda H., Swain S.L., Nussenzweig M., Steinman R.M. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. Journal of Cell Biology. 151:2000;673-683.
56. Maurer D., Stingl G. Langerhans cells. Lotze M.T., Thomson A.W. Dendritic Cells: Biology and Clinical Applications, 2nd ed. 2001;35-50 Academic Press, San Diego.
57. Mellman I., Steinman R.M. Dendritic cells. specialized and regulated antigen processing machines Cell. 106:2001;255-258.
58. Mellman I., Turley S.J., Steinman R.M. Antigen processing for amateurs and professionals. Trends in Cell Biology. 8:1998;231-237.
59. Olasz E.B., Linton J., Katz S.I. Soluble proteins and haptens on bone marrow-derived dendritic cells are presented to host CD4 T cells in an MHC-restricted manner. International Immunology. 14:2002;493-502.
60. Pennie W.D., Kimber I. Toxicogenomics. transcript profiling and potential application to chemical allergy Toxicology in Vitro. 16:2002;319-326.
61. Pichowski J.S., Cumberbatch M., Dearman R.J., Basketter D.A., Kimber I. Investigation of induced changes in interleukin 1β mRNA expression by cultured human dendritic cells as an in vitro approach to skin sensitization testing. Toxicology in Vitro. 14:2000;351-360.
62. Pichowski J.S., Cumberbatch M., Dearman R.J., Basketter D.A., Kimber I. Allergen-induced changes in interleukin 1β (IL-1β) mRNA expression by human blood-derived dendritic cells. inter-individual differences and relevance for sensitization testing Journal of Applied Toxicology. 21:2001;115-121.
63. Pierre P., Turley S.J., Gatti E., Hull M., Meltzer J., Mirza A., Inaba K., Steinman R.M., Mellman I. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature. 388:1997;787-792.
64. Reutter K., Jager D., Degwert J., Hoppe U. In vitro model for contact sensitization. II Induction of IL-1β mRNA in human blood-derived dendritic cells by contact sensitizers. Toxicology in Vitro. 11:1997;619-626.
65. Rizova H., Carayon P., Barbier A., Lacheretz F., Dubertret L., Michel L. Contact allergens, but not irritants, alter receptor-mediated endocytosis by human epidermal Langerhans cells. British Journal of Dermatology. 140:1999;200-209.
66. Romani N., Gruner S., Brang D., Kampgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P.O., Steinman R.M., Schuler G. Proliferating dendritic cells progenitors in human blood. Journal of Experimental Medicine. 180:1994;83-93.
67. Rustemeyer T., Van Hoogstraten I.M.W., Von Blomberg B.M.A. Mechanisms in allergic contact dermatitis. Rycroft R.J.G., Menne T., Frosch P. Lepoittevin, J-P. (Eds.), Textbook of Contact Dermatitis, 3rd edition. 2001;14-58 Springer, Berlin.
68. Ryan C.A., Hulette B.C., Gerberick G.F. Approaches for the development of cell-based in vitro methods for contact sensitization. Toxicology in Vitro. 15:2001;43-55.
69. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendiritic cells is maintained by granulocyte/macrophage colony stimulating factor plus interleukin-4 and down-regulated by tumor necrosis factor α Journal of Experimental Medicine. 179:1994;1109-1118.
70. Santambrogio L., Sato A.K., Carven G.J., Belyanskaya S.L., Strominger J.L., Stern L.J. Extracellular antigen processing and presentation by immature dendritic cells. Proceedings of the National Academy of Sciences USA. 96:1999;15056-15061.
71. Smith C.K., Hotchkiss S.A.M. Allergic Contact Dermatitis. Chemical and Metabolic Mechanisms. 2001;Taylor & Francis, London.
72. Thery C., Amigorena S. The cell biology of antigen presentation in dendritic cells. Current Opinion in Immunology. 13:2001;45-51.
73. Tuschl H., Kovac R. Langerhans cells and immature dendritic cells as model systems for screening skin sensitizers. Toxicology in Vitro. 15:2001;327-331.
74. Verrier A.C., Schmitt D., Staquet M.J. Fragrance and contact allergens in vitro modulate the HLA-DR and E-cadherin expression on human epidermal Langerhans cells. International Archives of Allergy and Immunology. 120:1999;56-62.